title: Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements.
abstract: The ALL-1 gene is directly involved in 5-10% of acute lymphoblastic leukemias (ALLs) and acute myeloid leukemias (AMLs) by fusion to other genes or through internal rearrangements. DNA microarrays were used to determine expression profiles of ALLs and AMLs with ALL-1 rearrangements. These profiles distinguish those tumors from other ALLs and AMLs. The expression patterns of ALL-1-associated tumors, in particular ALLs, involve oncogenes, tumor suppressors, antiapoptotic genes, drug-resistance genes, etc., and correlate with the aggressive nature of the tumors. The genes whose expression differentiates between ALLs with and without ALL-1 rearrangement were further divided into several groups, enabling separation of ALL-1-associated ALLs into two subclasses. One of the groups included 43 genes that exhibited expression profiles closely linked to ALLs with ALL-1 rearrangements. Further, there were evident differences between the expression profiles of AMLs in which ALL-1 had undergone fusion to other genes and AMLs with partial duplication of ALL-1. The extensive analysis described here pinpointed genes that might have a direct role in pathogenesis.
authors.affiliation: Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
authors.forename: T
authors.initials: T
authors.lastname: Rozovskaia
authors.forename: O
authors.initials: O
authors.lastname: Ravid-Amir
authors.forename: S
authors.initials: S
authors.lastname: Tillib
authors.forename: G
authors.initials: G
authors.lastname: Getz
authors.forename: E
authors.initials: E
authors.lastname: Feinstein
authors.forename: H
authors.initials: H
authors.lastname: Agrawal
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: E F
authors.initials: EF
authors.lastname: Rappaport
authors.forename: I
authors.initials: I
authors.lastname: Issaeva
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuo
authors.forename: U R
authors.initials: UR
authors.lastname: Kees
authors.forename: T
authors.initials: T
authors.lastname: Lapidot
authors.forename: F
authors.initials: F
authors.lastname: Lo Coco
authors.forename: R
authors.initials: R
authors.lastname: Foa
authors.forename: A
authors.initials: A
authors.lastname: Mazo
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: C M
authors.initials: CM
authors.lastname: Croce
authors.forename: G
authors.initials: G
authors.lastname: Cimino
authors.forename: E
authors.initials: E
authors.lastname: Domany
authors.forename: E
authors.initials: E
authors.lastname: Canaani
mesh_terms: D002869:Chromosome Aberrations; D002880:Chromosomes, Human, Pair 11; D002894:Chromosomes, Human, Pair 4; D016000:Cluster Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D015536:Down-Regulation; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000235:genetics*; D051788:Myeloid-Lymphoid Leukemia Protein; D020411:Oligonucleotide Array Sequence Analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000235:genetics*; D011519:Proto-Oncogenes; D014157:Transcription Factors; D014158:Transcription, Genetic; D014178:Translocation, Genetic; D015854:Up-Regulation
chemical_list: D004268:DNA-Binding Proteins; C497422:KMT2A protein, human; D014157:Transcription Factors; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase